256 related articles for article (PubMed ID: 30001985)
1. The Multiple Myeloma Drug Pipeline-2018: A Review of Small Molecules and Their Therapeutic Targets.
Abramson HN
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):611-627. PubMed ID: 30001985
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Applications of Small Molecules in the Treatment of Multiple Myeloma.
Abramson HN
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768967
[TBL] [Abstract][Full Text] [Related]
3. Emerging small molecule approaches to enhance the antimyeloma benefit of proteasome inhibitors.
Driscoll JJ; Brailey M
Cancer Metastasis Rev; 2017 Dec; 36(4):585-598. PubMed ID: 29052093
[TBL] [Abstract][Full Text] [Related]
4. Kinase inhibitors as potential agents in the treatment of multiple myeloma.
Abramson HN
Oncotarget; 2016 Dec; 7(49):81926-81968. PubMed ID: 27655636
[TBL] [Abstract][Full Text] [Related]
5. Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma.
Anreddy N; Hazlehurst LA
J Cell Biochem; 2017 Jan; 118(1):15-25. PubMed ID: 27261328
[TBL] [Abstract][Full Text] [Related]
6. Panobinostat: a review of trial results and future prospects in multiple myeloma.
Libby EN; Becker PS; Burwick N; Green DJ; Holmberg L; Bensinger WI
Expert Rev Hematol; 2015 Feb; 8(1):9-18. PubMed ID: 25410127
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease.
Ashjian E; Redic K
J Oncol Pharm Pract; 2016 Apr; 22(2):289-302. PubMed ID: 25694345
[TBL] [Abstract][Full Text] [Related]
8. An update in treatment options for multiple myeloma in nontransplant eligible patients.
Broijl A; Sonneveld P
Expert Opin Pharmacother; 2015; 16(13):1945-57. PubMed ID: 26245702
[TBL] [Abstract][Full Text] [Related]
9. Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins.
Magarotto V; Salvini M; Bonello F; Bringhen S; Palumbo A
Leuk Lymphoma; 2016; 57(3):537-56. PubMed ID: 26445358
[TBL] [Abstract][Full Text] [Related]
10. Treatment of MM: Upcoming Novel Therapies.
Lonial S
Cancer Treat Res; 2016; 169():195-205. PubMed ID: 27696264
[TBL] [Abstract][Full Text] [Related]
11. How I treat myeloma with new agents.
Moreau P
Blood; 2017 Sep; 130(13):1507-1513. PubMed ID: 28747306
[TBL] [Abstract][Full Text] [Related]
12. Novel agents in the treatment of multiple myeloma: a review about the future.
Naymagon L; Abdul-Hay M
J Hematol Oncol; 2016 Jun; 9(1):52. PubMed ID: 27363832
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of Multiple Myeloma: Promise and Challenges.
Abramson HN
Immunotargets Ther; 2021; 10():343-371. PubMed ID: 34527606
[TBL] [Abstract][Full Text] [Related]
14. Novel targeted therapies and combinations for the treatment of multiple myeloma.
Agarwal A; Mahadevan D
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):2-15. PubMed ID: 22882073
[TBL] [Abstract][Full Text] [Related]
15. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial.
Lonial S; Weiss BM; Usmani SZ; Singhal S; Chari A; Bahlis NJ; Belch A; Krishnan A; Vescio RA; Mateos MV; Mazumder A; Orlowski RZ; Sutherland HJ; Bladé J; Scott EC; Oriol A; Berdeja J; Gharibo M; Stevens DA; LeBlanc R; Sebag M; Callander N; Jakubowiak A; White D; de la Rubia J; Richardson PG; Lisby S; Feng H; Uhlar CM; Khan I; Ahmadi T; Voorhees PM
Lancet; 2016 Apr; 387(10027):1551-1560. PubMed ID: 26778538
[TBL] [Abstract][Full Text] [Related]
16. Contemporary drug therapies for multiple myeloma.
de la Puente P; Azab AK
Drugs Today (Barc); 2013 Sep; 49(9):563-73. PubMed ID: 24086952
[TBL] [Abstract][Full Text] [Related]
17. Resistance to proteasome inhibitors and other targeted therapies in myeloma.
Wallington-Beddoe CT; Sobieraj-Teague M; Kuss BJ; Pitson SM
Br J Haematol; 2018 Jul; 182(1):11-28. PubMed ID: 29676460
[TBL] [Abstract][Full Text] [Related]
18. Advances in targeted therapy for the treatment of patients with relapsed/refractory multiple myeloma.
Le Ray E; Jagannath S; Palumbo A
Expert Rev Hematol; 2016 Jan; 9(1):91-105. PubMed ID: 26558304
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies - A new era in the treatment of multiple myeloma.
Jelinek T; Hajek R
Blood Rev; 2016 Mar; 30(2):101-10. PubMed ID: 26362528
[TBL] [Abstract][Full Text] [Related]
20. Proteasome inhibitors for multiple myeloma.
Okazuka K; Ishida T
Jpn J Clin Oncol; 2018 Sep; 48(9):785-793. PubMed ID: 30102324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
